The intriguing Cyclophilin A-HIV-1 Vpr interaction: Prolyl cis/trans isomerisation catalysis and specific binding

BMC Structural Biology

Volumn 10, Issue , 2010, Pages

  Solbak, Sara M ^a   Reksten, Tove R ^a,b   Wray, Victor ^b   Bruns, Karsten ^b   Horvli, Ole ^a   Raae, Arnt J ^a   Henklein, Petra ^c   Henklein, Peter ^c   Röder, Rene ^c   Mitzner, David ^d   Schubert, Ulrich ^d   Fossen, Torgils ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHILIN A; ISOMERASE; PROLINE; VPR PROTEIN; PEPTIDYLPROLYL ISOMERASE; VPR PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOSENSOR; CATALYSIS; CIS ISOMER; ENZYME SUBSTRATE; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; ISOMERIZATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; TRANS ISOMER; HUMAN; KINETICS; MASS SPECTROMETRY; METABOLISM; NUCLEAR MAGNETIC RESONANCE; PHYSIOLOGY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CYCLOPHILIN A; HUMANS; KINETICS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDYLPROLYL ISOMERASE; PROLINE; PROTEIN BINDING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SURFACE PLASMON RESONANCE; VIRUS REPLICATION; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77957259243     PISSN: None     EISSN: 14726807     Source Type: Journal    
DOI: 10.1186/1472-6807-10-31     Document Type: Article

References (48)

1. Incorporation of Vpr into Human Immunodeficiency Virus Type 1 Virions: Requirement for the p6 Region of gag and Mutational Analysis. W Paxton RI Connor NR Landau, J Virol 1993 67 7229 37 8230445
2. HIV-1 Vpr Displays Natural Protein-Transducing Properties: Implications for Viral Pathogenesis. MP Sherman U Schubert SA Williams CMC de Noronha JF Kreisberg P Henklein WC Greene, Virology 2002 302 95 105 10.1006/viro.2002.1576 12429519
3. Induction of cell differentiation by human immunodeficiency virus 1 vpr. DN Levy LS Fernandes WV Williams DB Weiner, Cell 1993 72 541 550 10.1016/0092-8674(93)90073-Y 8440020
4. The Human Immunodeficiency Virus Type 1 vpr Gene Prevents Cell Proliferation during Chronic Infection. ME Rogel LI Wu M Emerman, J Virol 1995 69 882 888 7815556
5. Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis following Cell Cycle Arrest. SA Stewart B Poon JBM Jowett ISY Chen, J Virol 1997 71 5579 92 9188632
6. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor B. V Ayyavoo A Mahboubi S Mahalingam R Ramalingam S Kudchodkar WV Williams DR Green DB Weiner, Nature Med 1997 3 1117 1123 10.1038/nm1097-1117 9334723
7. Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G(2) cell cycle arrest. P Henklein K Bruns MP Sherman U Tessmer K Licha J Kopp CMC de Noronha WC Greene V Wray U Schubert, J Biol Chem 2000 275 32016 32026 10.1074/jbc.M004044200 10903315
8. Dynamic Distruption in Nuclear Envelope Architecture and Integrity Induced by HIV-1 Vpr. CMC de Noronha MP Sherman HW Lin MV Cavrois RD Moir RD Goldman WC Greene, Science 2001 294 1105 1108 10.1126/science.1063957 11691994
9. Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression. K Zander MP Sherman U Tessmer K Bruns V Wray AT Prechtel E Schubert P Henklein J Luban J Neidleman WC Greene U Schubert, J Biol Chem 2003 278 43202 43213 10.1074/jbc.M305414200 12881522
10. 2 Arrest and Binding to Cyclophilin A Are Independent Phenotypes of Human Immunodeficiency Virus Type 1 Vpr. O Ardon ES Zimmermann JL Andersen JL DeHart J Blackett V Planelles, J Virol 2006 80 3694 3700 10.1128/JVI.80.8.3694-3700.2006 16571786
11. Role of cyclophilin A in HIV replication. J Votteler V Wray U Schubert, Future Virol 2007 2 65 78 10.2217/17460794.2.1.65 (Pubitemid 46813453)
12. Catalysis of cis/trans isomerisation in native HIV-1 capsid by human CypA. DA Bosco EZ Eisenmesser S Pochapsky WI Sundsquist D Kern, PNAS 2002 99 5247 5252 10.1073/pnas.082100499 11929983
13. Catalysis and Binding of Cyclophilin A with Different HIV-1 Capsid Constructs. DA Bosco D Kern, Biochemistry 2004 43 6110 6119 10.1021/bi049841z 15147195
14. Functional association of cyclophilin A with HIV-1 virions. M Thali A Bukovsky E Kondo B Rosenwirth CT Walsh J Sodroski HG Göttlinger, Nature 1994 372 363 365 10.1038/372363a0 7969495
15. Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppresive cyclosporine analog. B Rosenwirth A Billich R Datema P Donatsch F Hammerschmid R Harrison P Hiestand H Jaksche P Mayer P Peichl V Quesniaux F Schatz HJ Schuurman R Traber R Wenger B Wolff G Zenke M Zurini, Antimicrob Agents Chemother 1994 38 1763 1772 7527198
16. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporine A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV Protein-cyclophilin A interactions. A Billich F Hammerschmid P Peichl R Wenger G Zenke V Quesniaux B Rosenwirth, J Virol 1995 69 2451 2461 7884893
17. Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. EK Franke J Luban, Virology 1996 222 279 282 10.1006/viro.1996.0421 8806510
18. Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions. T Dorfman A Weimann A Borsetti CT Walsh HG Göttlinger, J Virol 1997 71 7110 7113 9261445
19. Structural Characterization of the HIV-1 Vpr N Terminus. K Bruns T Fossen V Wray P Henklein U Tessmer U Schubert, J Biol Chem 2003 278 43188 43201 10.1074/jbc.M305413200 12881523
20. Specific incorporation of cyclophilin A into HIV-1 virions. EK Franke HEH Yuan J Luban, Nature 1994 372 359 362 10.1038/372359a0 7969494
21. Substrate Specificities of the Peptidyl Prolyl Cis- Trans Isomerase Activity of Cyclophilin and FK-506 Binding Protein: Evidence for the Existence of a Family of Distinct Enzymes. RK Harrison RL Stein, Biochemistry 1990 29 3813 3816 10.1021/bi00468a001 1693856
22. Maturation-induced Conformational Changes of HIV-1 Capsid Protein and Identification of Two High Affinity Sites for Cyclophilins in the C-termainal Domain. MM Endrich P Gehrig H Gehrig, J Biol Chem 1999 274 5326 5332 10.1074/jbc.274.9.5326 10026140
23. The cis/trans interconversion of the calcium regulating hormone calcitonin is catalyzed by cyclophilin. D Kern T Drakenberg M Wikström S Forsèn H Bang G Fischer, FEBS 1993 323 198 202 10.1016/0014-5793(93) 81338-Z (Pubitemid 23153468)
24. NMR structure of the HIV-1 regulatory protein Vpr in H2O/trifluoroethanol - Comparison with the Vpr N-terminal (1-51) and C-terminal (52-96) domains. K Wecker N Morellet S Bouaziz BP Roques, Eur J Biochem 2002 269 3779 3788 10.1046/j.1432-1033.2002.03067.x 12153575
25. NMR structure of the HIV-1 regulatory protein Vpr. N Morellet S Bouaziz P Petitjean BP Roques, J Mol Biol 2003 327 215 227 10.1016/S0022-2836(03)00060-3 12614620
26. A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: Potential impact on CTL epitopes. A Srinivasan V Ayyavoo S Mahalingam A Kannan A Boyd D Datta V Kalyanaraman A Cristillo RG Collman N Morellet BE Sawaya R Murali, Virology journal 2008 5 99 10.1186/1743-422X-5-99 18721481
27. Gag. Y Jenkins O Pornillos RL Rich DG Myszka WI Sundquist MH Malim, J Virol 2001 75 10537 42 10.1128/JVI.75.21.10537-10542. 2001 11581428
28. Proline 35 of human immunodeficiency virus type 1 (HIV-1) Vpr regulates the integrity of the N-terminal helix and the incorporation of Vpr into virus particles and supports the replication of R5-tropic HIV-1 in human lymphoid tissue ex vivo. J Votteler N Studtrucker S Sörgel J Münch E Rücker F Kirchhoff B Schick P Henklein T Fossen K Bruns A Sharma V Wray U Schubert, J Virol 2007 81 9572 9576 10.1128/JVI.02803-06 17553868
29. NMR Studies of the Rates of Proline Cis-Trans Isomerisation in Oligopeptides. C Grathwohl K Wüthrich, Biopolymers 1981 20 2623 2633 10.1002/bip.1981.360201209
30. Prolyl cis-trans isomerisation as a molecular timer in Crk signaling. LK Nicholson KP Lu, Mol Cell 2007 25 483 485 10.1016/j.molcel.2007.02.005 17317620
31. Peptidyl-Prolyl Cis-Trans Isomerase Activity of Cyclophilin Studied by One-Dimensional 'H Nuclear Magnetic Resonance Spectroscopy. VL Hsu RE Handschumacher IM Armitage, J Am Chem Soc 1990 112 6145 6141 10.1021/ja00174a064
32. Peptidyl-prolyl cis-trans isomerase activity as studied by dynamic proton NMR spectroscopy. D Hübner T Drakenberg S Forsén G Fischer, FEBS 1991 284 79 81 10.1016/0014-5793(91)80766-V
33. Kinetic Analysis of Cyclophilin-Catalyzed Prolyl CisRrans Isomerisation by Dynamic NMR Spectroscopy. D Kern G Kern G Scherer G Fischer T Drakenberg, Biochemistry 1995 34 13594 13602 10.1021/bi00041a039 7577948
34. Conformational state of a 25-mer peptide from the cyclophilin-binding loop of the HIV type 1 capsid protein. U Reimer M Drewello M Jakob G Fischer M Schutkowski, Biochem J 1997 326 181 185 9337866
35. HIV protease substrate conformation: modulation by cyclophilin A. MA McCornack LT Kakalis C Caserta RE Handschumacher IM Armitage, FEBS Lett 1997 414 88 10.1016/S0014-5793(97)00974-5 (Pubitemid 27380360)
36. Substrate anchoring and the catalytic power of enzymes. J Reuben, PNAS 1971 68 563 565 10.1073/pnas.68.3.563 5276762
37. Enzyme Dynamics During Catalysis. EZ Eisenmesser DA Bosco M Akke D Kern, Science 2002 295 1520 1523 10.1126/science.1066176 11859194
38. Survey of the year 2006 commercial optical biosensor literature. RL Rich DG Myszka, J Mol Recognit 2007 20 300 366 10.1002/jmr.862 18074396
39. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. TR Gamble FF Vajdos SH Yoo DK Worthylake M Houseweart WI Sundquist CP Hill, Cell 1996 87 1285 1294 10.1016/S0092-8674(00)81823-1 8980234
40. Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV-1 capsid protein. FF Vajdos S Yoo M Houseweart WI Sundquist CP Hill, Prot Sci 1997 6 2297 2307 10.1002/pro.5560061103
41. Cyclophilin A binds to linear peptide motifs containing a consensus that is present in many human proteins. K Piotukh W Gu M Kofler D Labudde V Helms C Freund, J Biol Chem 2005 280 23668 23674 10.1074/jbc.M503405200 15845542
42. Cloning, expression, and purification of human cyclophilin in Escherichia coli and assessment of the catalytic role of cysteines by site-directed mutagenesis. J Liu MW Albers CM Chen SL Schreiber CT Walsh, Proc Natl Acad Sci USA 1990 87 2304 2308 10.1073/pnas.87.6.2304 2179953
43. In Vitro Assembly Properties of Wild-Type and Cyclophilin-Binding Defective Human Immunodeficiency Virus Capsid Proteins in the Presence and Absence of Cyclophilin A. M Grättinger H Hohenberg D Thomas T Wilk B Müller HG Kräusslich, Virology 1999 257 247 260 10.1006/viro.1999.9668 10208938
44. Water Suppression That Works. Excitation Sculpting Using Arbitrary Wave-Forms and Pulsed-Field Gradients. TL Hwang AJ Shaka, J Magn Reson 1995 112 275 279 10.1006/jmra.1995.1047
45. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. A Bax DG Davis, J Magn Reson 1985 65 355 360
46. NMR of Proteins and Nucleic Acids. K Wüthrich, John Wiley and Sons, Inc. New York 1986
47. SPARKY 3. TD Goddard DG Kneller, University of California, San Francisco http://www.cgl.ucsf.edu/home/sparky/
48. Enhancing the Proline Effect: Pseudo-Prolines for Tailoring Cis/Trans Isomerisation. M Keller C Sager P Dumy M Schutkowski M Fischer GS Mutter, J Am Chem Soc 1998 120 2714 2720 10.1021/ja973966s (Pubitemid 28191626)